GPCR Heteromer-based Sensors and Systems for Diverse Applications
Legal Citation
Summary of the Inventive Concept
The present inventive concept leverages the core technology of GPCR heteromer inhibitors to develop novel sensors and systems for monitoring and controlling various environmental and biological parameters, enabling new applications in smart cities, disease detection, wearable devices, agriculture, and cybersecurity.
Background and Problem Solved
The original patent focused on GPCR heteromer inhibitors for cancer treatment, but the technology's potential extends far beyond oncology. The present inventive concept addresses the need for innovative sensors and systems that can accurately detect and respond to diverse environmental and biological stimuli, filling a significant gap in existing technologies.
Detailed Description of the Inventive Concept
The inventive concept comprises GPCR heteromer-based sensors that can detect specific molecules or signals, which are then processed by data analytics modules to generate actionable insights. In the context of smart cities, the sensors can monitor air quality and provide real-time maps and alerts. For disease detection, the GPCR heteromers can serve as biomarkers to identify and track infectious diseases. In wearable devices, the sensors can monitor stress levels and provide personalized recommendations. In agriculture, the sensors can detect plant stress and optimize crop yields. Finally, in cybersecurity, the GPCR heteromers can detect and prevent specific types of cyber attacks.
Novelty and Inventive Step
The new claims introduce a paradigm shift in the application of GPCR heteromer technology, moving from cancer treatment to diverse fields such as environmental monitoring, disease detection, wearable devices, agriculture, and cybersecurity. The inventive concept's novelty lies in the recognition of GPCR heteromers as versatile sensors and biomarkers, enabling the development of innovative systems and applications.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different GPCR heteromers, sensor configurations, or data analytics modules to tailor the system to specific applications. Variations could also involve the integration of additional components, such as machine learning algorithms or IoT connectivity, to enhance the system's capabilities.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including smart cities, healthcare, wearable devices, agriculture, and cybersecurity. The market for GPCR heteromer-based sensors and systems is expected to grow rapidly, driven by the increasing demand for innovative solutions in these fields.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K38/195 |
| A | A61 | A61K31/138 |
| A | A61 | A61K31/395 |
| A | A61 | A61K31/403 |
| A | A61 | A61K31/451 |
| A | A61 | A61K31/4545 |
| A | A61 | A61K31/47 |
| A | A61 | A61K31/495 |
| A | A61 | A61K31/5415 |
| A | A61 | A61K38/12 |
| A | A61 | A61K39/3955 |
| A | A61 | A61P35/00 |
| C | C07 | C07K16/286 |
| C | C07 | C07K16/2866 |
| A | A61 | A61K2039/505 |
| A | A61 | A61K2039/507 |
| C | C07 | C07K2317/21 |
| C | C07 | C07K2317/76 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Molecular Biology, Pharmacology, and Biotechnology with expertise in G-Protein Coupled Receptor (GPCR) heteromer interactions, signal transduction, and sensor technologies
Person of Ordinary Skill (PHOSITA) Profile
A researcher or engineer with advanced degrees in molecular biology or bioengineering, experienced in GPCR interactions, signal transduction mechanisms, and interdisciplinary sensor design with knowledge of protein engineering and biotechnology applications
Obviousness Rationale
A PHOSITA would recognize the inherent versatility of GPCR heteromer technologies demonstrated in the source patent and understand that their signal detection capabilities could be readily extended to diverse sensing applications. The fundamental mechanism of heteromer-based signal transduction provides a predictable platform for developing sensors across multiple domains. The PTD's variations represent logical extrapolations of the core GPCR heteromer technology by applying known signal detection principles to different contextual environments.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,600 |
|---|---|
| Title | GPCR heteromer inhibitors and uses thereof |
| Assignee(s) | GPCR THERAPEUTICS, INC. |